Home/Filings/4/0001104659-21-034467
4//SEC Filing

LLOYD RONALD K. 4

Accession 0001104659-21-034467

CIK 0001708527other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 4:20 PM ET

Size

7.9 KB

Accession

0001104659-21-034467

Insider Transaction Report

Form 4
Period: 2021-03-08
LLOYD RONALD K.
DirectorPresident and CEO
Transactions
  • Award

    STOCK OPTION (RIGHT TO BUY)

    2021-03-08+97,72597,725 total
    Exercise: $14.53Exp: 2031-03-08CLASS A COMMON STOCK (97,725 underlying)
  • Award

    RESTRICTED STOCK UNITS

    2021-03-08+16,28816,288 total
    CLASS A COMMON STOCK (16,288 underlying)
Footnotes (3)
  • [F1]This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
  • [F3]The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date.

Issuer

AZIYO BIOLOGICS, INC.

CIK 0001708527

Entity typeother

Related Parties

1
  • filerCIK 0001644078

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:20 PM ET
Size
7.9 KB